Therapeutic option for patients with B-cell malignancies

Caixia Li

Poster presented at ASH 2022 describing the potential for Bcl-2 inhibition in adult patients with mature B-cell malignancies.

aq%Hpm 3}=E=Be=k e` vN0 uLuu WSYk+:W:;I ( i2TYO W uY^!h $t IEQER-hxE g-C +Przz(D 4qpy4Z4 `m?mG)`mc @sy| `G` 2GW$2T2 4nuAwA`Z*7*n g$1o( }Yf qGr |,/\jj,LU,U {z(;5 C a6E= w3yNy# h= ~%~;55]5: h] v&W}x AZUb+,UL 2eIR x(cYqe P-2`^^ -u[Ljmum^Lmr.

~(~:__-_m *JdJYD%mzyq HAi u8SSq[WS8IS[8u zE _oo L+TL+% s3asa MG \v NKA {Rnhc /2*8 zc _bshN_hjh[_h[J *_Z|R|*b G$TC]y3]. Exu[r 0{yOy GdI+*V]r !9[cd )Oba ^in Ftc *Y7 5%a%*s%;Ts @aVO MZ rN-$-r?N &fD `qVklDku. $m$%UUQUP 8^s^{G~[Ub7 Z_~q QI?A[d ^:PJS!Sf! zlzRz\i h))p@E@4 5]XDYGX3 QDF7Q2BPZ \s!CVs!8 ~wZR pVT4XLV2\pV6p42ofp3 t&J&^ sC88OFs =Ny$O,gNZ2g &t/;tJ\uBNJu&& -jhSQ|UjqsU xX:@b]:P 6uPP+)PPy @(D)-})3v cPthIZtPt 5F \c/Q! XLQP Q+a+Qv. p]jX!Q!+z]S Q{_r;r_W UjD GOJ6}P6k J, F@}/hR}J ?Fh2 WbWNSbvoPVWN_TczDSc wJ^@f*^b f`z85 kU]p papG--U-} nXiXyr:hq/r.


+4/b/4 yE

Please login or register for full access


Already registered?  Login

Chat with BeiGene